Moderna, Inc. (MRNA)
NASDAQ·Healthcare·Biotechnology
$47.16
-3.17%
Mkt Cap $21.42B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 13, 2026 | $635.15M | $678.00M | +6.75% | -$2.54 | -$2.11 | +16.93% | — | — |
| Q4 2025 Nov 6, 2025 | $920.86M | $1.02B | +10.33% | -$1.87 | -$0.51 | +72.73% | — | — |
| Q3 2025 Aug 1, 2025 | $893.29M | $142.00M | -84.10% | -$2.99 | -$2.13 | +28.76% | — | — |
| Q2 2025 May 1, 2025 | $116.75M | $107.00M | -8.35% | -$2.92 | -$2.52 | +13.70% | — | — |
| Q1 2025 Feb 14, 2025 | $942.82M | $956.00M | +1.40% | -$2.68 | -$2.50 | +6.72% | — | — |
| Q4 2024 Nov 7, 2024 | $1.25B | $1.85B | +48.39% | -$1.91 | $0.03 | +101.57% | — | — |
| Q3 2024 Aug 1, 2024 | $128.41M | $241.00M | +87.68% | -$3.35 | -$3.33 | +0.60% | — | — |
| Q2 2024 May 2, 2024 | $93.26M | $167.00M | +79.07% | -$3.56 | -$3.07 | +13.76% | — | — |
| Q1 2024 Feb 22, 2024 | $2.51B | $2.81B | +12.02% | -$0.97 | $0.55 | +156.70% | — | — |
| Q4 2023 Nov 2, 2023 | $1.32B | $1.83B | +38.27% | -$2.01 | -$1.39 | +30.85% | — | — |
| Q3 2023 Aug 3, 2023 | $319.64M | $344.00M | +7.62% | -$3.84 | -$3.62 | +5.73% | — | — |
| Q2 2023 May 4, 2023 | $1.18B | $1.84B | +56.01% | -$1.77 | $0.19 | +110.73% | — | — |
| Q1 2023 Feb 23, 2023 | $5.02B | $5.08B | +1.33% | $4.68 | $3.61 | -22.86% | — | — |
| Q4 2022 Nov 3, 2022 | $3.53B | $3.22B | -8.69% | $3.29 | $2.53 | -23.10% | — | — |
| Q3 2022 Aug 3, 2022 | $4.10B | $4.57B | +11.45% | $4.55 | $5.24 | +15.16% | — | — |
| Q2 2022 May 4, 2022 | $4.20B | $5.94B | +41.30% | $5.21 | $8.58 | +64.68% | — | — |
| Q1 2022 Feb 24, 2022 | $6.80B | $6.95B | +2.23% | $9.90 | $11.29 | +14.04% | — | — |
| Q4 2021 Nov 4, 2021 | $6.45B | $4.83B | -25.09% | $9.05 | $7.70 | -14.92% | — | — |
| Q3 2021 Aug 5, 2021 | $4.21B | $4.21B | +0.18% | $5.96 | $6.46 | +8.39% | — | — |
| Q2 2021 May 6, 2021 | $2.41B | $1.74B | -27.80% | $2.39 | $2.84 | +18.83% | — | — |